AlphaStocks
6.7
Consider Buy

Becton Dickinson & Co (BDX)

As of Sep 20, 2026, Becton Dickinson & Co (BDX) scores 6.7/10 on AlphaStocks' five-model composite, #20 of 168 Health Care stocks. At $181, BDX trades 21% above its model fair value of $149.

Health Care / Health Care Equipment

S&P 500

$180.78

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#20out of 168 in Health Care

Is BECTON DICKINSON & CO a Good Investment in 2026?

BECTON DICKINSON & CO (BDX) scores 6.7 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Buffett model rates BECTON DICKINSON & CO as Strong. However, the Lynch model rates it Caution — High PEG — growth premium · Slow Grower. BECTON DICKINSON & CO currently trades 21% above its estimated fair value of $149. BECTON DICKINSON & CO ranks #20 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E31.1ROE6.6Market Cap51BDiv Yield2.7

Estimated Fair Value

$149.0321% above

Trading above estimated fair value. Eps growth of -1% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Strong

Business quality & competitive moat

Graham

Caution

42% above fair value

Lynch

Caution

High PEG — growth premium · Slow Grower

Greenblatt

Strong

Earnings yield 13.1% · ROC >100%

Frequently Asked Questions

Is BECTON DICKINSON & CO (BDX) a good investment?
As of Sep 20, 2026, Becton Dickinson & Co (BDX) scores 6.7/10 on AlphaStocks' five-model composite, #20 of 168 Health Care stocks. At $181, BDX trades 21% above its model fair value of $149. That is a middle-of-the-pack score with no strong signal either way.
What is BECTON DICKINSON & CO's Piotroski F-Score?
BECTON DICKINSON & CO's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is BDX overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $149, BDX appears overvalued. The stock currently trades 21% above its estimated fair value. Trading above estimated fair value. Eps growth of -1% may not justify the premium.
How does BDX compare to other Health Care stocks?
BECTON DICKINSON & CO ranks #20 out of 168 stocks in the Health Care sector, placing it in the top 12% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about BDX?
AlphaStocks evaluates BDX using five proven investment models. Piotroski: Attractive; Buffett: Strong; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 6.7/10.

Similar Stocks

INSPUFPTDXCM

Compare BDX with

BDX vs INSPBDX vs UFPTBDX vs DXCMBDX vs VALBDX vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer